SCHEMBL12373225

SCHEMBL12373225

NOC(=O)c1ccc(Cl)c(N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.52
ALDH1A1 P00352 6/20 0.52
HPGD P15428 5/20 0.52
HSD17B10 Q99714 4/20 0.52
KMT2A Q03164 3/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 2/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798285 0.84 TSHR (0.57) KDM4EALDH1A1HPGDKMT2ARAB9A
SCHEMBL30391548 0.83 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL51589 0.83 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL999927 0.82 ALDH1A1 (0.48) KDM4EALDH1A1HPGDHSD17B10KMT2A
Hydrochloric Acid SCHEMBL4717368 0.81 KDM4E (0.64) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL10893735 0.80 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL312298 0.79 SRD5A2 (0.53) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL2686416 0.79 ALOX15 (0.50) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL28212582 0.79 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL5076653 0.79 ALDH1A1 (0.61) KDM4EALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201576-A1 Small molecule inhibitors of stat3 with anti-tumor activity H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE (US) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201576-A1 Small molecule inhibitors of stat3 with anti-tumor activity STAT3, STAT1, STAT5A KDM4E 4097/4885ALDH1A1 3674/4885HPGD 4416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.